Increased risk for cancer after stroke at a young age: etiological relevance or incidental finding?
- 24 Downloads
Etiological factors, such as a malignant disease, in young stroke patients are often neglected. Therefore, in this study, we aimed to investigate the risk of developing cancer in young stroke survivors.
The current case–control study sample included patients who received an initial ischemic stroke diagnosis documented in the Disease Analyzer database (IQVIA), which compiles data such as risk factors, drug prescriptions, and diagnoses obtained from general practitioners and specialists.
The stroke and non-stroke groups included 18,668 patients each; each group had 2836 (15.3%) participants ≤ 55 years. The cancer incidence in the stroke group over the age of 55 years was higher than in the younger subgroup (29.4% versus 17.3%). The proportions of cancer patients within 10 years of follow-up were higher in the stroke group versus the non-stroke group, as well as in the subgroup of patients aged ≤ 55 versus patients > 55 years (17.3% versus 9.5% and 29.4% versus 24.9%, respectively). The calculated hazard ratio for developing cancer within 10 years of follow-up was higher in the younger stroke population (≤ 55 years) than in the older population (hazard ratio: 1.47 (CI 1.18–1.83) versus 1.17 (CI 1.10–1.25).
In our cohort, young individuals aged ≤ 55 years who suffered a stroke had twice as high risk for developing cancer within 10 years after the index event compared to the control group. Stroke might have implication regarding the subsequent development of cancer and vice versa.
KeywordsYoung stroke Cancer Stroke etiology
No funding was received for this study.
Compliance with ethical standards
Conflict of interest
All authors report to have no conflicts of interest or competing interests related to the current manuscript.
- Aigner A, Busch MA, Grittner U (2017) Response by Aigner et al to letter regarding article, “Contribution of established stroke risk factors to the burden of stroke in young adults”. Stroke 48:e316Google Scholar
- Chen CW, Cheng TJ, Ho CH, Wang JJ, Weng SF, Hou YC et al (2017) Increased risk of brain cancer incidence in stroke patients: a clinical case series, population-based and longitudinal follow-up study. Oncotarget 8:108989–108999Google Scholar
- Dearborn JL, Urrutia VC, Zeiler SR (2014) Stroke and cancer- A complicated relationship. J Neurol Transl Neurosci 2:1039Google Scholar
- Donati MB (1995) Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice. Thromb Haemost 74:278–281Google Scholar
- Kozera-Strzelinska D, Karlinski M, Rak G, Wojdacz M, Sienkiewicz-Jarosz H, Kurkowska-Jastrzebska I (2019) Stroke and TIA mimics in patients referred to a neurological emergency department by non-ambulance physicians, ambulance physicians and paramedics. Neurol Neurochir Polska 53:83–89Google Scholar
- Prandoni P, Bernardi E, Valle FD, Visona A, Tropeano PF, Bova C (2016) Extensive computed tomography versus limited screening for detection of occult cancer in unprovoked venous thromboembolism: a multicenter, controlled, randomized clinical trial. Semin Thromb Hemost 42:884–890CrossRefGoogle Scholar
- Tanislav C, Grittner U, Misselwitz B, Jungehuelsing GJ, Enzinger C, von Sarnowksi B et al (2014) Lessons from everyday stroke care for clinical research and vice versa: comparison of a comprehensive and a research population of young stroke patients. BMC Neurol. https://doi.org/10.1186/1471-2377-14-45 Google Scholar